Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

OBJECTIVES: To identify the most efficacious timing for tocilizumab administration in critically ill patients infected with severe acute respiratory syndrome coronavirus-2. DESIGN: Observational multicenter cohort study. SETTING: A total of 23 acute care hospitals in four states. PATIENTS: One-hundr...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrak, Russell M., Van Hise, Nicholas W., Skorodin, Nathan C., Fliegelman, Robert M., Chundi, Vishnu, Didwania, Vishal, Han, Alice, Harting, Brian P., Hines, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009634/
https://www.ncbi.nlm.nih.gov/pubmed/33817660
http://dx.doi.org/10.1097/CCE.0000000000000395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009634/
https://www.ncbi.nlm.nih.gov/pubmed/33817660
http://dx.doi.org/10.1097/CCE.0000000000000395

Ejemplares similares